Quarterback 2b - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer

NCT02945631 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced HPV Positive Oropharynx Cancer

Interventions

RADIATION: PTV56
RADIATION: PTV50.4

Sponsor

Icahn School of Medicine at Mount Sinai